The discrepancy of the role of CASC15 gene polymorphisms in neuroblastoma risk might be attributed to (1) relative small sample sizes in the validation studies and (2) the variation in allele frequencies, linkage disequilibrium patterns, and environmental exposures among different ethnic populations that influence cancer risk [32]. The gene discussed is CASC15; the disease is cancer.